Notice to Extend the Expiration Date for PAR-16-021 "NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01)"

Notice Number: NOT-HL-18-645

Key Dates
Release Date: August 21, 2018

Related Announcements
PAR-16-021

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform interested applicants that the expiration date for the Funding Opportunity Announcement (FOA) PAR-16-021, "NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01)" will be extended by one council round (changes shown in bold italics below). This FOA has been modified to expire on January 19, 2019. NHLBI strongly encourage investigators focusing on sickle cell and other rare blood disorders such as bone marrow and hemophilia, to respond. Applicants are also encouraged to propose other ‘omics’ including microbiome measurements to address a specific hypothesis.

Part 1. Overview Information

Key Dates

The Key Dates table is updated accordingly:

Application Due Date(s)

January 19, 2016, January 19, 2017, October 19, 2017, October 18, 2018, January 18, 2019

AIDS Application Due Date(s)

Not Applicable

Scientific Merit Review

June 2016, June 2017, March 2018, March 2019, June 2020

Advisory Council Review

Not Applicable

Earliest Start Date(s)

September 2016, September 2017, July 2018, July 2019, September 2020

Expiration Date

January 19, 2019

Due Dates for E.O. 12372

Not Applicable

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Pankaj Qasba, Ph.D. 
National Heart, Lung, and Blood Institute (NHLBI)
Telephone:  301-435-0050 
Email: qasbap@nhlbi.nih.gov